These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5989065)

  • 21. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of Persantin on the pressure overloaded dog heart].
    Siska K; Holec V; Fedelesová M; Ziegelhöffer A
    Z Kreislaufforsch; 1968 Feb; 57(2):119-27. PubMed ID: 5671893
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of hypoxia and acidosis on the dog heart.
    Roy PE; Morin PJ; Gailis L; Côté G
    J Cardiovasc Surg (Torino); 1970; 11(6):460-71. PubMed ID: 5504366
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of hypoxia-induced rise in adenosine release and flow by coronary dilators.
    Kukovetz WR; Pöch G
    Cardiology; 1971; 56(1):107-13. PubMed ID: 5152736
    [No Abstract]   [Full Text] [Related]  

  • 25. [The comparative studies on the influence of persantin on the coronary circulation in dogs and rabbits].
    Filczewski M; Oledzka K; Nowicka J
    Acta Physiol Pol; 1969; 20(1):155-63. PubMed ID: 5793303
    [No Abstract]   [Full Text] [Related]  

  • 26. [Distribution of dipyridamole, a selective coronary dilating substance, between plasma, cellular and aqueous phase in man and dogs. A contribution on the dosage of the drug in man].
    Kübler W; Bretschneider HJ; Spieckermann PG
    Arzneimittelforschung; 1969 Feb; 19(2):185-90. PubMed ID: 5818756
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocardial ultrastructure in acute and chronic hypoxia.
    Ferrans VJ; Roberts WC
    Cardiology; 1971; 56(1):144-60. PubMed ID: 4949412
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

  • 29. [THE EFFECT OF 2,6-BIS(DIETHANOLAMINO)-4,8-DIPIPERDINO-PYRIMIDO(5,4-D)PYRIMIDINE(PERSANTIN) ON THE CORONARY CIRCULATION, OXYGEN UPTAKE AND SUBSTRATE UPTAKE OF THE HUMAN HEART].
    RUDOLPH W; BERNSMEIER A; HENSELMANN L; BAEDEKER WD; HOFMANN H
    Klin Wochenschr; 1964 Jul; 42():667-74. PubMed ID: 14250907
    [No Abstract]   [Full Text] [Related]  

  • 30. Morphologic and biochemical studies of dog heart mitochondria after short periods of ischemia.
    Ekholm R; Kerstell J; Olsson R; Rudenstam CM; Svanborg A
    Am J Cardiol; 1968 Sep; 22(3):312-8. PubMed ID: 4299193
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contents and role of adenosine in the heart and blood vessels].
    Czyzewicki T
    Pol Tyg Lek; 1971 Jun; 26(4):926-9. PubMed ID: 4936842
    [No Abstract]   [Full Text] [Related]  

  • 32. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracoronary nitroglycerin, pentaerythritol trinitrate and dipyridamole on intramyocardial oxygen tension.
    Weiss HR; Winbury MM
    Microvasc Res; 1972 Jul; 4(3):273-84. PubMed ID: 4625491
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes of the coronary arteriovenous O2 difference in the man following intravenous injection of dipyridamol (Persantin)].
    Hilger HH; Wagner J; Hellwig H; Louven B; Wackerbauer J; Schaede A
    Z Kreislaufforsch; 1967 Dec; 56(12):1192-206. PubMed ID: 5593119
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the therapy of chronic coronary insufficiency].
    Steim H; Heilmeyer L
    Med Klin; 1966 Aug; 61(31):1223-8. PubMed ID: 5988938
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the effect of dipyridamole and propranolol on coronary circulation in human subjects with and without coronary heart disease.
    Takezawa H; Kitamura H; Komada M; Tanimura H; Masui K
    Jpn Circ J; 1968 Nov; 32(11):1565-9. PubMed ID: 5756393
    [No Abstract]   [Full Text] [Related]  

  • 37. Qualitative morphology of heart failure. Light and electron microscopic characteristics of acute and chronic heart failure.
    Büchner F
    Methods Achiev Exp Pathol; 1971; 5():60-120. PubMed ID: 4949549
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of dipyridamole (Persantin) in reducing the infarct size following experimental coronary occlusion.
    Watanabe T; Shintani F; Fu L; Kato K; Koyama S
    Jpn Heart J; 1972 Nov; 13(6):512-20. PubMed ID: 4539940
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ultrastructural study of the myocardium of rats treated with dipyridamole and subjected to swimming exercises].
    Jiménez-Castellanos MR; Moreno J; López-Campos JL
    Rev Clin Esp; 1984 Sep; 174(6):237-41. PubMed ID: 6522705
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental study of the effects of persantin on the coronary circulation and myocardial metabolism in basal conditions].
    LAURENT D; CHEVRIER JL; MOUQUIN M
    Presse Med (1893); 1961 Nov; 69():2292-4. PubMed ID: 14462835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.